IRIS
MANNI, ALESSIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 922
EU - Europa 243
AS - Asia 147
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 1
Totale 1.315
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 914
SE - Svezia 78
CN - Cina 72
SG - Singapore 64
IT - Italia 59
DE - Germania 19
RU - Federazione Russa 19
FI - Finlandia 18
GB - Regno Unito 15
BE - Belgio 11
CA - Canada 8
FR - Francia 7
VN - Vietnam 6
LT - Lituania 4
UA - Ucraina 4
CZ - Repubblica Ceca 2
EU - Europa 2
HK - Hong Kong 2
AL - Albania 1
AU - Australia 1
BD - Bangladesh 1
BG - Bulgaria 1
IE - Irlanda 1
IN - India 1
IS - Islanda 1
LK - Sri Lanka 1
LV - Lettonia 1
MK - Macedonia 1
RO - Romania 1
Totale 1.315
Salva come PNG Salva come JPEG
Città #
Fairfield 145
Chandler 122
Woodbridge 109
Ashburn 75
Nyköping 65
Houston 55
Seattle 55
Singapore 55
Cambridge 46
Wilmington 30
Ann Arbor 29
Beijing 23
Lawrence 17
Roxbury 15
Helsinki 13
Munich 12
Bari 11
Brussels 11
Des Moines 10
Jacksonville 9
Bisceglie 8
Inglewood 8
Princeton 7
Toronto 7
Brooklyn 6
Dong Ket 6
Los Angeles 6
Paris 6
Shenyang 6
Gravina in Puglia 5
Guangzhou 5
London 5
Nanjing 5
Santa Clara 5
Shanghai 5
Boardman 4
Frankfurt am Main 4
New York 4
Norwalk 4
Dearborn 3
Grottaglie 3
Lviv 3
Redwood City 3
San Diego 3
Washington 3
Brno 2
Guiyang 2
Hebei 2
Hong Kong 2
Imbersago 2
Jesi 2
Jinhua 2
Milan 2
Tianjin 2
Altamura 1
Chengdu 1
Chicago 1
Colombo 1
Dalian 1
Dhaka 1
Dublin 1
Fano 1
Florence 1
Hamilton 1
Hangzhou 1
Hefei 1
Hounslow 1
Irvine 1
Jiaxing 1
Jinan 1
Kansas City 1
Keflavik 1
Kilburn 1
Leawood 1
Leninsk-kuznetskiy 1
Lilienthal 1
Melbourne 1
Middlesex 1
Mottola 1
Nantong 1
New Bedfont 1
Ningbo 1
Nuremberg 1
Phoenix 1
Pune 1
Quzhou 1
Riga 1
Romola 1
Santa Marinella 1
Shenzhen 1
Sofia 1
Taranto 1
Tirana 1
Torino 1
Trani 1
Weifang 1
Wuhan 1
Totale 1.092
Salva come PNG Salva come JPEG
Nome #
Long-term cardiac safety and tolerability of fingolimod in multiple sclerosis: A postmarketing study 134
The cost of relapsing-remitting multiple sclerosis patients who develop neutralizing antibodies during interferon beta therapy 110
Gender differences in safety issues during Fingolimod therapy: Evidence from a real-life Relapsing Multiple Sclerosis cohort 109
Lymphocyte subsets as biomarkers of therapeutic response in Fingolimod treated Relapsing Multiple Sclerosis patients 108
Retrospectively acquired cohort study to evaluate the long-term impact of two different treatment strategies on disability outcomes in patients with relapsing multiple sclerosis (RE.LO.DI.MS): data from the Italian MS Register 101
Lymphocyte count and body mass index as biomarkers of early treatment response in a multiple sclerosis dimethyl fumarate-treated cohort 96
Long-Term Data of Efficacy, Safety, and Tolerability in a Real-Life Setting of THC/CBD Oromucosal Spray-Treated Multiple Sclerosis Patients 95
Development and validation of the ID-EC - The ITALIAN version of the identify chronic migraine 82
The role of neutralizing antibodies to interferon-β as a biomarker of persistent MRI activity in multiple sclerosis: a 7-year observational study 75
Durvalumab and multiple sclerosis: a causal link or simple unmasking? 54
Defining the course of tumefactive multiple sclerosis: a large retrospective multicentre study 47
Personalizing Cancer Pain Therapy: Insights from the Rational Use of Analgesics (RUA) Group 47
null 44
Magnetoencephalography and high‐density electroencephalography study of acoustic event related potentials in early stage of multiple sclerosis: A pilot study on cognitive impairment and fatigue 42
Effect of cladribine on neuronal apoptosis: New insight of in vitro study in multiple sclerosis therapy 40
Longitudinal Evaluation of Serum MOG-IgG and AQP4-IgG Antibodies in NMOSD by a Semiquantitative Ratiometric Method 37
Risk of Getting COVID-19 in People With Multiple Sclerosis 33
Efficacy and Safety of Oral Therapies for Relapsing-Remitting Multiple Sclerosis 28
Macular ganglion cell-inner plexiform layer defect patterns in multiple sclerosis patients without optic neuritis: A Spectral-Domain-Optical Coherence Tomography Cross-Sectional, Case-Control, Pilot Study 27
Conversion to secondary progressive multiple sclerosis: Patient awareness and needs. Results from an online survey in Italy and Germany 20
Impact of depression on the perception of fatigue and information processing speed in a cohort of multiple sclerosis patients 19
A case report of late-onset atypical Hemolytic Uremic Syndrome during interferon beta in multiple sclerosis: Open issues in literature review 17
Real-Life Experience of the Effects of Cladribine Tablets on Lymphocyte Subsets and Serum Neurofilament Light Chain Levels in Relapsing Multiple Sclerosis Patients 16
Neutralizing Antibodies and Multiple Sclerosis in the Era of Disease Modifying Treatments 12
Dancing With Parkinson's Disease: The SI-ROBOTICS Study Protocol 8
Clinical and biological predictors of Cladribine effectiveness in Multiple Sclerosis: A real-world, single Centre study considering a two-year interval from year-2 dosing 7
Multiple Sclerosis Progression and Relapse Activity in Children 6
Totale 1.414
Salva come PNG Salva come JPEG
Categoria #
all - tutte 8.320
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.320
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020182 0 0 0 0 0 0 32 39 34 28 39 10
2020/2021228 18 13 15 31 19 17 29 17 12 21 19 17
2021/2022149 13 4 2 5 8 20 5 9 10 12 27 34
2022/2023292 37 49 19 21 35 32 9 35 34 1 8 12
2023/2024115 18 17 5 16 16 15 3 6 1 7 0 11
2024/2025210 36 4 49 32 34 55 0 0 0 0 0 0
Totale 1.414